In Focus from the latest issue— Potent Personalized #Venetoclax Partners for #AcuteMyeloidLeukemia Identified by Ex Vivo Drug Screening, by Pamela S. Becker. https://t.co/VU30ONFEcY @cityofhope #AMLsm #precisionmedicine #TheSFPM https://t.co/KB4B5yB2mH
3,046 followers
3,046 followers
In Focus from the November issue— Potent Personalized #Venetoclax Partners for #AcuteMyeloidLeukemia Identified by Ex Vivo Drug Screening, by Pamela S. Becker. https://t.co/Ti6lyeI8EF @cityofhope #AMLsm #precisionmedicine #TheSFPM https://t.co/Kraa5hHKMJ
3,046 followers
Potent Personalized #Venetoclax Partners for #AcuteMyeloidLeukemia Identified by Ex Vivo Drug Screening, by Pamela S. Becker. https://t.co/mMXJzbBEqn @cityofhope #AMLsm #precisionmedicine #TheSFPM https://t.co/2BisVNqaTk
31 followers
RT @BCD_AACR: Potent Personalized #Venetoclax Partners for #AcuteMyeloidLeukemia Identified by Ex Vivo Drug Screening, by Pamela S. Becker.…